Roch Houot
Inserm(FR)Inserm(FR)Université Rennes 2(FR)The Lymphoma Academic Research Organisation(FR)CIC Rennes(FR)Hôpital Pontchaillou(FR)Centre Hospitalier Universitaire de Rennes(FR)Centre Hospitalier Universitaire de Rennes(FR)Microenvironment and B-cells: Immunopathology, Cell, Differentiation and Cancer(FR)Université de Rennes(FR)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction
Most-Cited Works
- → KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma(2020)1,759 cited
- → KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study(2021)737 cited
- → Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma(2017)402 cited
- → Intratumoral immunotherapy: using the tumor as the remedy(2017)358 cited
- → A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma(2022)355 cited
- → Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network(2019)